A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
NCT02932449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 711
Last updated 2026-02-18
Summary
This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.
Conditions
- Biliary Cirrhosis, Primary
Sponsors & Collaborators
-
Target PharmaSolutions, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2025-01-23
- Completion
- 2025-01-23
Countries
- United States
Study Locations
More Related Trials
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05293938 ·Status: WITHDRAWN
-
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT06755541 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
NCT02135536 ·Status: COMPLETED ·Phase: PHASE2
-
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
NCT06365424 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
NCT06699121 ·Status: RECRUITING ·Phase: PHASE2
-
A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics
NCT06591468 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Pilot Study of FFP104 Dose Escalation in PBC Subjects
NCT02193360 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NCT06755151 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
NCT03742973 ·Status: TERMINATED ·Phase: PHASE2
-
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
NCT01614405 ·Status: TERMINATED ·Phase: NA
-
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
NCT02308111 ·Status: TERMINATED ·Phase: PHASE4
-
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
NCT06591455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
NCT01430429 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
NCT06905054 ·Status: RECRUITING ·Phase: PHASE2
-
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT02846896 ·Status: COMPLETED
-
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
NCT02177136 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
NCT01688024 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
NCT01662973 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Use of Fenofibrate for Primary Biliary Cirrhosis
NCT00575042 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
NCT07282353 ·Status: RECRUITING ·Phase: PHASE3
-
Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis
NCT03668145 ·Status: UNKNOWN ·Phase: NA